TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
TRAX

First Tracks Biotherapeutics, Inc.

Healthcare · Biotechnology · —

36.70$ -10.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TRAX
Line item Q1 25 Q1 26 Q2 26
– – -37.0%
– – -38.6%
– -35.5% -32.4%
– -25.7% -41.3%
– – -56.7%
– – -62.4%
– – –
– – -65.9%
– -34.3% -34.4%
– – –
– +0.0% +1.8%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?